Spain Carlos Mateos, founder and CEO of Spanish digital healthcare PR specialist, COM Salud, discusses opportunities for the healthcare sector in eHealth and big data as well as the benefits that holding eHealth congresses in Spain can bring to the entire healthcare sphere. What was the idea behind the creation of…
Spain Dr. Ángel Navarro, president of Azierta discusses how the company’s strategy of linking science and business has created a consultancy space through which to offer a wide range of healthcare-related services to the worldwide science environment. Additionally, he emphasizes the importance of retaining strong talent in the industry and having…
Spain Eduardo Lopez-Puertas, managing director of IFEMA, Spain’s largest and most successful congress center, discusses the country’s competitive advantages compared to the rest of Europe, and the role the pharmaceutical sector plays in their strategy to contribute to Spain’s economy. Can you please introduce IFEMA to our international readers and its…
Spain Jose Manuel Rigueiro, general manager of the Spanish affiliate of Actelion, discusses the lack of trust between health authorities and the industry and the challenges of launching new orphan drugs in such a fragmented healthcare system. He highlights the successful launch of Uptravi® and his commitment to avoid business disruption…
Spain Jesus Aguilar Santamaria, president of the General Pharmaceutical Council of Spain (CGCOF) discusses the role of the council in the Spanish healthcare system, in addition to exploring the benefits of the recent digital changes to the sector and how these changes drive the Council to continue the improvement of the…
Spain Jaime Malet, president of the US Chamber of Commerce (AmCham) in Spain, discusses the importance of the trade relations between the US and Spain, with eight percent of GDP made up by American companies, the Chamber’s commitment to make Spain an attractive investment hub, the strategic assets that Spain as…
Spain Carlos Teixeira, CEO of Teva Spain and Portugal, discusses the challenges the generic sector is facing in Spain, which ultimately spurred the company towards other business opportunities, and highlights the significant footprint of the Spanish affiliate, with its manufacturing site in Zaragoza serving as an export base for Europe and…
Spain Eva Prada, director of the British Chamber of Commerce in Spain, discusses trade relations between the UK and Spain and the activities of the Chamber in developing trust-based business relationships between companies and the government, their collaboration with key institutions such as ICEX, as well as their intention to work…
Spain Regina Múzquiz, director general of the Spanish Biosimilar Medicines Association (BioSim), discusses the importance of biosimilars as a tool to alleviate costs to the healthcare system and save EUR two billion in three years. Additionally, she points out the recent legal proposals on public procurement and reference pricing system that…
Spain Jose Escribano, founder of Spanish biotech success story ALGENEX, discusses the company’s focus on using insects in its research, difficulties in accessing capital, and its future growth strategy. Can you please start by describing the opportunities that presented themselves, allowing you to create ALGENEX? “What we have done is to…
Spain Jaume Pey, director general at the Spanish Association of Self-care (ANEFP), discusses the growth projections of the self-care segment in Spain, the impact that the ‘supresión del control previo sanitario’ (suppression of prior health control) has had on the advertising campaigns of ANEFP’s members, as well as the importance of…
Spain Concha Almarza, general manager at IQVIA Spain, discusses the changes that the Spanish pharmaceutical market has witnessed over the last few years, highlighting the stringent cost-containment measures aimed at improving patient access to complex innovative drugs, the stabilization of generics penetration urging producers to expand their offering to other segments,…
See our Cookie Privacy Policy Here